ArticleScientific reports2025

Development, verification, and comparison of a risk stratification model to identify potential population benefiting from chemotherapy in non-metastatic male breast cancer.

Mingkun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.